Honorable Robert Bunda

President of the Senate

Twenty-Third State Legislature

Regular Session of 2006

State of Hawaii

Sir:

Your Committees on Health and Human Services, to which was referred H.B. No. 3105, H.D. 2, entitled:

beg leave to report as follows:

The purpose of this measure is to provide fee-for-service mental health consumers improved access to psychotropic medications, repeal the pre-authorization exemption for psychotropic medications, and repeal the requirement that the Department of Human Services report on the costs and effects of the Act.

Your Committees received testimony in support of this measure from the Hawaii Medical Service Association and NAMI Oahu. Your Committees received testimony in support of the intent of this measure with suggested amendments from the Department of Human Services, the Hawaii Disability Rights Center, and the Hawaii Psychiatric Medical Association. Your Committees received testimony in opposition to this measure from Kaiser Permanente.

Your Committees find that open access to psychotropic medications is necessary for successful treatment of mental illnesses. Equal access should be made available to all individuals participating in Hawaii medicaid medical plans. Testimony submitted by the Department of Human Services, the Hawaii Disability Rights Center, and the Hawaii Psychiatric Medical Association suggested amending this measure by removing the QUEST exclusion.

Your Committees have amended this measure by replacing its contents with the contents of S.B. No. 3224, SD2 which:

As affirmed by the records of votes of the members of your Committees on Health and Human Services that are attached to this report, your Committees are in accord with the intent and purpose of H.B. No. 3105, H.D. 2, as amended herein, and recommend that it pass Second Reading in the form attached hereto as H.B. No. 3105, H.D. 2, S.D. 1, and be referred to the Committee on Ways and Means.